openPR Logo
Press release

Lyme Disease - Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

02-28-2023 03:40 AM CET | Health & Medicine

Press release from: Global Insight Services

Lyme Disease

Lyme Disease

As per Global Insight services' assessment, about 10+ prominent pharma and biotech giants are working on 20+ drugs in the Lyme Disease - pipeline landscape globally. Lyme Disease Pipeline Insight, 2023" report by Global Insight Services provides a comprehensive analysis of the ongoing clinical development activities and growth prospect.

Download PDF Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key Companies: https://www.globalinsightservices.com/request-sample/GIS31230

Key Players

Abzyme Therapeutics
Aegis Life
Blue Lake Biotechnology
Cortene Inc
MassBiologic Inc
Tarsus Pharmaceuticals, Inc.
Valneva Austria GmbH
Report Highlights

Global Insight Service's, Lyme Disease - Drug Pipeline Landscape, 2023 report provides an overview of the Lyme disease pipeline drugs. This report covers detailed insights on Lyme Disease drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Lyme Disease pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Buy Now: https://www.globalinsightservices.com/checkout/single_user/GIS31230

Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like
- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I)
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust and transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lyme Disease - Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here

News-ID: 2951324 • Views:

More Releases from Global Insight Services

Submersible Pump Market Is Anticipated To Expand From $14.5 Billion In 2024 To $21.8 Billion By 2034
Submersible Pump Market Is Anticipated To Expand From $14.5 Billion In 2024 To $ …
Market Overview The Submersible Pump Market is anticipated to expand from $14.5 billion in 2024 to $21.8 billion by 2034, registering a steady CAGR of approximately 4.2%. Submersible pumps are designed for submerged operations in various fluids, enabling efficient water extraction, sewage treatment, and oil and gas applications. These pumps are extensively used across sectors such as agriculture, municipal infrastructure, and industrial processes, offering reliable performance in demanding environments. The market's
Special Mission Aircraft Market Is Anticipated To Expand From $17.3 Billion In 2024 To $29.9 Billion By 2034
Special Mission Aircraft Market Is Anticipated To Expand From $17.3 Billion In 2 …
Market Overview The Special Mission Aircraft Market is witnessing substantial expansion, driven by the rising need for versatile and technologically advanced aircraft tailored for unique operational roles. These aircraft are not limited to traditional transport duties but are equipped for specific missions such as intelligence gathering, surveillance, reconnaissance, search and rescue, and maritime patrol. As defense and homeland security agencies worldwide focus on enhancing situational awareness and operational efficiency, the Special
Medical Tourism Market Is Anticipated To Expand From $115.6 Billion In 2024 To $346.1 Billion By 2034
Medical Tourism Market Is Anticipated To Expand From $115.6 Billion In 2024 To $ …
Market Overview The Medical Tourism Market has emerged as a transformative force within the global healthcare ecosystem, offering patients an affordable and accessible alternative to high-cost treatments in their home countries. It represents a growing trend where individuals travel abroad to receive medical services ranging from elective cosmetic procedures to complex surgeries. The demand surge is primarily fueled by cost-effectiveness, high-quality care, shorter waiting times, and the availability of advanced treatments
Magnetic Sensor Market Is Anticipated To Expand From $5.42 Billion In 2024 To $12.48 Billion By 2034
Magnetic Sensor Market Is Anticipated To Expand From $5.42 Billion In 2024 To $1 …
Market Overview The Magnetic Sensor Market is anticipated to expand from $5.42 billion in 2024 to $12.48 billion by 2034, growing at a CAGR of approximately 8.7%. This rapid growth reflects the rising integration of magnetic sensing technologies across diverse industries such as automotive, consumer electronics, healthcare, and industrial automation. These sensors are essential for detecting magnetic fields and translating them into electrical signals, enabling applications like navigation, position sensing, current

All 5 Releases


More Releases for Lyme

Lyme Disease Diagnostics Market Projected to Show Strong Growth
Advance Market Analytics published a new research publication on "Lyme Disease Diagnostics Market Insights, to 2033" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Lyme Disease Diagnostics market was mainly driven by the increasing R&D spending across the world. Get Free Exclusive PDF Sample
Lyme Disease - Drug Pipeline Landscape, 2022
Lyme disease is a tick-borne infection caused by four main species of bacteria Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii. The disease is characterized by skin rash. Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems. To know more about Lyme Disease - Drug Pipeline ,
Lyme Disease - Drug Pipeline Landscape, 2022 | Global Insight Services
Lyme disease is a tick-borne infection caused by four main species of bacteria Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii. The disease is characterized by skin rash. Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems. Diagnosis of Lyme disease involves lab tests to
Lyme Disease Vaccines - Are They Effective?| Valneva, GlaxoSmithKline Plc.
There is currently no Lyme disease vaccine available. LYMERix®, the only vaccine previously marketed in the United States, was withdrawn from the market in 2002 due to a lack of consumer demand. The vaccine's effectiveness deteriorates over time. Lyme Disease Vaccines Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing
Lyme Disease Therapeutics Market Size Statistics, Facts and Figures
Global Lyme Disease Therapeutics Market: Overview Lyme disease is a contagious disease caused by a bacterium species called Borrelia burgdorferi. It is a tick-borne disease caused by transmission of bacteria to humans through the bite of infected ticks. Common indications of Lyme disease include flu-like symptoms, depression, fatigue, and expanding, circular, reddish skin rashes. View Report : https://www.transparencymarketresearch.com/lyme-disease-therapeutics-market.html If left untreated, these symptoms may worsen and can lead to partial or complete
Lyme Disease Diagnostic Testing Market
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs